Parkinson’s Awareness Month: Finding Help with Medication Costs

Last Updated on April 2, 2026

Parkinson’s disease affects nearly one million Americans, making it the second most common neurodegenerative disease in the United States. During Parkinson’s Awareness Month — and on World Parkinson’s Day, observed every April 11 — we want to make sure patients and caregivers know that help is available, especially when it comes to affording the medications that help manage this disease day to day.

At NeedyMeds, we maintain a free database of patient assistance programs, discount options, and financial resources that can help reduce your out-of-pocket costs. Here’s a guide to finding help for commonly prescribed Parkinson’s disease medications.


Carbidopa-Levodopa: The Gold Standard Treatment

Carbidopa-levodopa is the most widely prescribed and most effective medication for managing Parkinson’s motor symptoms. It works by replenishing dopamine in the brain, and is available in several formulations — immediate release, extended release, and even inhaled or infused forms for advanced disease. Sinemet (carbidopa/levodopa) — The most commonly prescribed formulation; available as immediate-release tablets

Rytary (carbidopa/levodopa extended release) — An extended-release capsule that reduces “off” time between doses

Inbrija (levodopa inhalation powder) — An inhaled form of levodopa used specifically for “off” episodes between doses


Dopamine Agonists

Dopamine agonists mimic the effects of dopamine in the brain. They are often prescribed in early Parkinson’s, or used alongside carbidopa-levodopa as the disease progresses. Mirapex (pramipexole) — One of the most commonly prescribed dopamine agonists, available in immediate and extended-release forms

Requip (ropinirole) — Another widely used dopamine agonist, also available in extended-release form

Neupro (rotigotine) — A dopamine agonist delivered as a once-daily skin patch; useful for patients who have difficulty swallowing pills


MAO-B Inhibitors

MAO-B inhibitors work by blocking the enzyme that breaks down dopamine in the brain, allowing more dopamine to remain available. They can be used alone in early Parkinson’s or added to carbidopa-levodopa therapy later. Azilect (rasagiline) — The only MAO-B inhibitor FDA-approved as a standalone therapy for Parkinson’s; also used as an add-on

Xadago (safinamide) — An add-on MAO-B inhibitor for patients experiencing “off” episodes while on carbidopa-levodopa

Eldepryl / selegiline — An older MAO-B inhibitor still used for early-stage or adjunctive treatment


COMT Inhibitors

COMT inhibitors extend the effect of each levodopa dose by slowing the enzyme that breaks it down. They are always used as add-on therapy with carbidopa-levodopa. Comtan (entacapone) — The most widely used COMT inhibitor

Ongentys (opicapone) — A newer once-daily COMT inhibitor


Managing Dyskinesia

Gocovri (amantadine extended release) — FDA-approved specifically to treat dyskinesia (involuntary movements) caused by levodopa therapy


Financial Assistance Programs for Parkinson’s Patients

Beyond medication-specific programs, several organizations offer broader financial support for people living with Parkinson’s disease.

Diagnosis-Based Assistance Programs

NeedyMeds maintains a dedicated list of organizations that provide financial assistance specifically for Parkinson’s patients — including help with copays, treatment costs, and other expenses.


More Ways NeedyMeds Can Help

Our resources go beyond what’s listed here. Use these tools to find additional assistance:


Living with Parkinson’s disease is a daily challenge — and worrying about the cost of medication shouldn’t be part of it. This Parkinson’s Awareness Month, take a few minutes to explore the resources available to you. You might be surprised at how much help is out there. All NeedyMeds resources are free to use. We’re a 501(c)(3) nonprofit organization dedicated to helping people afford their medications and healthcare costs.

About Me

Related Posts

About Us

Welcome to the NeedyMeds Voice! We look forward to presenting you with timely, provocative pieces on healthcare reform, patient advocacy, medication and healthcare access, and other health-related news. Our goals are to educate, enlighten, and elucidate; together, we will try to make sense of the myriad and ongoing healthcare-related changes in the U.S. today.